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Abstract
Background: Acute viral respiratory infections are an important cause of morbidity and mortality in humans
worldwide. The etiological backgrounds of these infections remain unconfirmed in most clinical cases. The aim of
this study was to estimate the prevalence of human coronavirus infections in a series of children hospitalized with
symptoms of acute respiratory tract disease in a one-year period in Slovenia.
Methods: The 664 specimens from 592 children under six years of age hospitalized at the University Children’s
Hospital in Ljubljana were sent for the routine laboratory detection of respiratory viruses. Respiratory viruses were
detected with a direct immunofluorescence assay and human coronaviruses were detected with a modified
real-time RT–PCR.
Results: HCoV RNA was detected in 40 (6%, 95% CI: 4.3%–8.1%) of 664 samples. Of these specimens, 21/40 (52.5%)
were identified as species HKU1, 7/40 (17.5%) as OC43, 6/40 (15%) as 229E, and 6/40 (15%) as NL63. Infection with
HCoV occurred as a coinfection with one or more other viruses in most samples (70%). Of the HCoV-positive
children, 70.3% had lower respiratory tract infections.
Conclusion: The results of our study show that HCoV are frequently detected human pathogens, often associated
with other respiratory viruses and acute respiratory tract infections in hospitalized children. An association between
age and the viral load was found. The highest viral load was detected in children approximately 10 months of age.
Keywords: Hospitalized children, Human coronavirus, Respiratory viral infection
Background
Acute infections of the respiratory tract are a major
cause of morbidity and mortality in humans worldwide
and approximately 80% are caused by viruses [1,2].
The viruses most frequently associated with respiratory
tract infections include respiratory syncytial virus (RSV),
parainfluenza viruses (PIV), influenza viruses (Flu), ade-
noviruses (AdV), human rhinoviruses (hRV), and entero-
viruses, and less commonly, human metapneumovirus
(hMPV), human bocavirus (HBoV), and human corona-
viruses (HCoV). Until recently, it was believed that
HCoVs were responsible for the common cold syndrome
and were the cause of only mild upper respiratory tract
infections (URTIs) [3]. After the SARS epidemic in 2003,
it was established that these viruses can also be asso-
ciated with severe, life-threatening, or even fatal
respiratory infections [4]. Stewart at al. have also sug-
gested a possible relationship between HCoV infections
and the development of extrarespiratory symptoms, in-
cluding some involving the central nervous system [5].
The role of HCoV in human gastrointestinal infections
also awaits more detailed exploration [6,7].
The aim of this study was to estimate the prevalence
of HCoV in a series of hospitalized infants and young
children with symptoms of respiratory tract disease at
the University Children’s Hospital in Ljubljana from June
2007 to May 2008. The main focus of the present study
was to detect all four human coronaviruses in hospita-
lized children. A proportion of the patients included in
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Children’s Hospital in Ljubljana with acute respiratory
tract infections (ARTIs), were sent to the laboratory of
the Institute of Microbiology and Immunology, Faculty
of Medicine, University of Ljubljana, for the routine de-
tection of respiratory viruses. The number of patients
included in this study represented virtually all of hospi-
talized children with diagnosis of viral respiratory tract
infection in this period.
Of these, 664 (74%) respiratory specimens (nasopha-
ryngeal and throat swabs in viral transport medium,
tracheal aspirates, bronchoalveolar lavage, or sputum)
from 592 preschool children aged from three days to
72 months were included in to further analysis. Each of
the 664 samples represented a different hospitalization
event, except for one child from whom two different
samples were taken and submitted for analysis (nasopha-
ryngeal swab and bronchoalveolar lavage). Remaining
233 (26%) respiratory specimens were collected from
149 children either older than 72 months or were taken
during the same hospitalization event. Therefore these
specimens were excluded from the further analysis.
Demographic and clinical data were extracted from
the children’s medical records and were available for 37
HCoV-positive children and 395 HCoV-negative children.
The present study was approved by the National Med-
ical Ethics Committee, Ljubljana, Slovenia (no. 60/02/09).
Laboratory investigations
Total nucleic acids were isolated from 190 μL of each re-
spiratory specimen using a total nucleic acid isolation kit
on a MagNA Pure Compact instrument (Roche Applied
Science, Mannheim, Germany), according to the manu-
facturer’s instructions. An additional 5 μL of equine her-
pesvirus 1 and equine arteritis virus isolates were
included in the nucleic acid extraction as internal con-
trols and were detected in separate duplex PCR reac-
tions with other specific targets [9,10].
The specimens were initially tested with direct im-
munofluorescence assays (DFAs; Oxoid, Cambridge, UK)
for RSV, Flu A/B, PIV1-3, and AdV. After the routine
detection assays, the remaining samples were stored fro-
zen until their nucleic acid extraction.
All four human coronaviruses (229E, OC43, NL63,
and HKU1) were detected with a modified coronavirus
consensus real-time RT–PCR assay performed on a Ste-
pOne Real-Time PCR System (Applied Biosystems, Fos-
ter City, USA) to amplify 85–100-bp fragments of the
polymerase 1b gene [11]. The real-time RT–PCR assays
were performed as one-step reactions (SuperScript III
Platinum One-Step Quantitative RT–PCR System; Invi-
trogen, CA, USA) within a single tube and a final vol-
ume of 20 μL, containing 5 μL of RNA and additional
6 mM MgSO4. The cycling conditions were as follows:
20 min at 50°C, 2 min at 95°C, and 45 cycles of 15 s
at 95°C and 45 s at 60°C. All samples that were positive
in the coronavirus screening assay were analyzed with a
subtype-specific assay in which all the coronavirus spe-
cies were detected separately [11]. All the specimens
were also subsequently tested with real-time RT–PCR
for the presence of hRV [12], hMPV [13], and HBoV
[14] using previously published assays.
The relative quantity of viral RNA was estimated from
the Ct values (cycle threshold; the cycle number at
which the real-time fluorescent signal of the amplifica-
tion target was above the background noise level) of the
real-time PCR. A lower Ct value was interpreted as indi-
cating a higher viral load.
Statistical analysis
Categorical data are summarized as frequencies (%) and
numerical data as medians (range).
The association between age and HCoV viral load was
assessed with a linear regression model. Restricted cubic
splines [15] were used to flexibly model the relationship
between Ct in the HCoV assays and patient age. The shape
of the estimated association is presented graphically [16].
We considered nine clinical characteristics (fever,
oxygen support required, cough, rhinorrhea, dyspnea,
wheezing, vomiting, location of the respiratory tract in-
fection, and bronchiolitis) and used univariate logistic
regression models with Firth’s correction to assess the
association between HCoV positivity (covariate) and
each clinical characteristic (response variables; these
models are indicated as “models (a)” in the Results sec-
tion). We further defined a three-category variable for
the HCoV results: HCoV negative, HCoV positive with
monoinfection, and HCoV positive with coinfection. We
fitted an additional set of univariate models using the
new variables as the covariates (“models (b)”). Only the
first hospitalization for each child was considered in this
analysis. The results are presented as odds ratios (OR)
with 95% confidence intervals (95% CI) and P values.
The R statistical language was used for the analyses [16].
Results
From June 2007 to May 2008, 664 specimens were col-
lected from 592 children under six years of age with
ARTI. The median age was 17.7 months (interquartile
range: 9–28 months). The female: male ratio was 1:1.3
(256/592; 43% females). The 664 samples comprised 542
(81.5%) nasopharyngeal swabs, 102 (15.4%) throat swabs,
and 20 (3%) other respiratory samples (i.e., tracheal
aspirates).
Virus detection
Overall, in 70.6% of samples, one or more viruses were
confirmed with the combined results of RT–PCR and
DFA. The prevalence of RSV, FluA, FluB, PIV1, PIV3,
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and AdV according to DFA was 12%, 0.1%, 0.1%, 1.2%,
0.6%, and 1%, respectively. PIV2 was not detected during
the study. Human coronavirus RNA was detected in 40
(6%; 95% CI: 4.3%–8.1%) of the 664 samples, 33/40
(82.5%) in nasopharyngeal swab, 6/40 (15%) in throat
swabs and 1/40 (2.5%) in bronchoalveolar lavage. Of the
40 specimens positive for coronavirus, 21/40 (52.5%)
were HKU1, 7/40 (17.5%) were OC43, 6/40 (15%) were
229E, and 6/40 (15%) were NL63. All specimens were
also tested with real-time RT–PCR for hRV, HBoV, and
hMPV. The most common virus detected was hRV
(37.6%), followed by HBoV (20.9%) and hMPV (11.3%).
Most HCoV infections were detected in winter (22/40,
55%) and spring (10/40, 25%), whereas 6/40 (15%) posi-
tive samples were collected in autumn and only 2/40
(5%) in summer. The association between HCoV positiv-
ity and seasonality was statistically significant (P < 0.001).
February had the highest number of HCoV-positive spe-
cimens (12/40, 30%), whereas HCoV was not detected in
June or July (Figure 1).
Of the 40 HCoV-positive samples, only 12 (30%) were
shown to involve only one virus, including 3/6 229E, 2/7
OC43, 5/21 HKU1, and 1/6 NL63. Species 229E was
most frequently detected as a monoinfection (50%), but
one or more other viruses were identified in the majority
(28/40, 70%) of coronavirus-positive samples: 21/40
(52.5%) were dual infections, 6/40 (15%) were triple
infections, and four viruses were detected simultan-
eously in one infection (2.5%). The viruses most fre-
quently detected with HCoV were hRV (42.8%), HBoV
(32.1%), RSV (28.6%), hMPV (21.4%), and AdV (3.6%).
On average, children with HCoV infections were older
than those negative for HCoV (median ages in months:
23 vs 18 months, respectively), but infection with HCoV
and age were not significantly associated (regardless of
whether age was treated as a continuous or a categorical
variable; data not shown). However, age was associated
with the estimated quantity of HCoV viral nucleic acids
present (measured as Ct). The association was nonlinear
(P < 0.001) and the highest estimated viral load (lowest
Ct) was detected in children around 10 months old. The
estimated viral load increased with age for children
younger than 10 months, whereas it decreased between
10 and 24 months. The estimated shape of the associ-
ation is shown in Figure 2.
Clinical features
Clinical data were available for 37 (92.5%) of the 40
HCoV-positive specimens and for 395/624 (63.3%) of
the HCoV-negative specimens. The majority (70.3%) of
HCoV-positive children were diagnosed with lower re-
spiratory tract infections (LRTIs: bronchiolitis 56.7%,
pneumonia 13.5%, bronchitis 5.4%, and recurrent wheez-
ing 8.1%). The remaining patients (29.7%) had URTIs.
Oxygen support during their hospital stay was required
by 17/37 (45.9%) HCoV-positive children and the me-
dian duration was three days. The symptoms associated
with HCoV are shown in Table 1.
The HCoV-positive children required significantly less
oxygen support and had less cough, dyspnea, wheezing,
LRTI, and bronchiolitis than HCoV-negative children
(Table 2; models (a)). The differences in the clinical fea-
tures of the HCoV-positive and HCoV-negative children
were very similar to those observed between HCoV-
positive children with monoinfections and HCoV-
negative children (Table 2; models (b)), indicating that
Figure 1 Seasonal distribution of positive results for coronavirus and other detected viruses.
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monoinfection with HCoV was associated with distinct
clinical features. The only exception was the URTIs,
which were more common among HCoV-positive chil-
dren (28% for HCoV-positive children vs 5% for HCoV-
negative children). Children with HCoV and coinfections
had URTIs significantly more frequently than HCoV-
negative children, and less frequently than HCoV-
monoinfected children, the difference was statistically
significant (P < 0.001) (4/10 = 40% among those with
HCoV monoinfections, 6/26 = 23% among those with
HCoV coinfections, and 18/373 = 5% among the HCoV-
negative children).
An underlying medical condition was present in 11/37
(29.7%) HCoV infected patients, whereas the other
HCoV-positive patients in this group were previously
healthy. Four children with underlying disease carried
HCoV as a single pathogen. Species 229E was more
likely to be detected as a single infection than were the
other viruses. Conversely, HKU1 was more likely to be
detected as a coinfection with other viruses than as a
monoinfection in children with an underlying medical
condition. More than one virus was detected in 76.9% of
HCoV-positive children without an underlying disease
or immunodeficiency. HKU1 was detected as the only
viral pathogen in a nasopharyngeal swab and bronchoal-
veolar lavage from a 9.7-month-old child with bronchio-
litis who was previously healthy.
Because the number of cases in our study was small,
no comparison of all the symptoms was made with a lo-
gistic regression model, nor was a comparison of the dif-
ferent coronavirus species and their associations with
clinical symptoms possible. No differences were found
between the CT values of the HCoV-positive samples
according to the different clinical outcomes (data not
shown).
Discussion
In our study, human coronavirus RNA was detected in
6% of respiratory samples from hospitalized children
with ARTI. This prevalence was lower than we have
found previously [8] and similar to that in other studies
(from 2.6% to 8.7%) [17-20]. The majority of positive
samples contained the HKU1 (52.5%) and the other cor-
onavirus species were detected less frequently. A similar
prevalence has been reported by Kuypers, and the preva-
lences of the HCoV species were reported in the same
order [11]. There may be regional and annual variations
in the circulation of different coronavirus species, as
have been described by others [19]. HCoV was most
often detected in winter and spring (80%), with the max-
imum number of cases presenting in February, whereas
only 20% of samples were positive for HCoV in autumn
and summer. Coronavirus infections have also been
strongly associated with seasonality in previously pub-
lished studies [20-23].
The children included in our study were under six
years of age (median, 17.7 months). The probability of
infection with HCoV was not significantly associated
with age. However, the HCoV-infected patients in our
study were older than those negative for HCoV. Some
studies have included populations from all age groups
[21,24,25], and coronaviruses have been detected in adults
[26-29], young children [30-34], and neonates [35].
The association between age and the estimated viral
load (from the Ct value) was interesting. The highest
viral load was estimated for children about 10 months
old (lower viral loads were detected in HCoV-infected
children younger or older than 10 months). One reason
for the highest viral load at this age may be the presence
of maternal antibodies directed to HCoVs in younger
infants [36].
The small number of cases and high number of HCoV
coinfections with other respiratory viruses limited our
ability to determine whether specific clinical signs or
symptoms were associated with coronavirus infections.
We compared only group of children infected with
HCoV and those without HCoV infections. In our ana-
lysis children negative to all tested viruses were not
included, because there is still uncertainty about possible
infection with some of the newly described viruses
(which were not included in our testing array). Children
infected with HCoV required significantly less oxygen
support, and had less cough, dyspnea, wheezing, LRTI,
and bronchiolitis than the HCoV-negative children. URTIs
were more frequent among HCoV-positive patients with
monoinfections than among HCoV-negative children. As
Figure 2 Estimated association between age and HCoV viral
load (Ct).
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in other similar studies, we had only a relatively small
number of coronavirus-positive samples. So far, only a few
studies have included sufficient patients to permit a statis-
tical comparison of the clinical outcomes of infections
with different HCoV species [19,21,37]. It has recently
been reported that coronavirus-infected children have
LRTI less frequently than those infected with other viruses
[38]. Children with coinfections had less severe disease
than those with single virus infections. Children under 5
months of age had higher prevalence of single virus
Table 2 Odds ratios for the HCoV results according to the clinical characteristics
Models (a) Models (b)
HCoV negative vs HCoV
positive (n = 395 vs 37)
HCoV positive with coinfection vs
HCoV positive with monoinfection
(n = 26 vs 11)
HCoV negative vs HCoV
positive with monoinfection
(n = 395 vs 11)
OR 95% CI P OR 95% CI P OR 95% CI P
Specific symptoms Fever 0.76 0.35,1.67 0.49 0.37 0.07,1.96 0.24 0.37 0.09,1.51 0.17
Oxygen support required 2.46 1.18, 5.17 0.02 7.63 0.99,58.61 0.05 11.62 1.79,75.64 0.01
Cough 2.03 0.93, 4.41 0.07 8.75 1.41,54.37 0.02 9.43 1.97,45.23 0.01
Rhinorrhea 0.63 0.28,1.40 0.26 6.81 1.17,39.80 0.03 2.36 0.56,9.93 0.24
Dyspnea 6.85 3.18,14.76 <0.001 7.63 0.99,58.61 0.05 32.26 4.90,213.37 <0.001
Wheezing 2.79 1.28, 6.07 0.01 3.28 0.43,25.16 0.25 6.76 1.04, 43.92 0.05
Vomiting 0.48 0.14, 1.61 0.23 2.90 0.11,74.05 0.52 0.99 0.05, 21.13 >0.99
Diagnoses LRTI vs URTI 7.61 2.97,19.54 <0.001 2.62 0.44,15.54 0.29 15.72 3.26,75.81 <0.001
Bronchiolitis 5.48 2.50,11.99 <0.001 5.72 0.96,33.94 0.05 19.58 4.03,95.12 <0.001
Key: The odds ratios and 95% CIs were derived from univariate logistic regression models. In models (a): the outcome is the presence of the specific symptom,
HCoV positivity is the covariate, and the reference category is “HCoV positive”. In models (b), the outcome is the presence of the specific symptom, the covariate
HCoV has three categories (HCoV positive with a monoinfection, HCoV positive with coinfection, and HCoV negative), and the reference category is “HCoV positive
with monoinfection”.
Table 1 Demographic and clinical data for patients with and without human coronavirus infections
HCoV positive patients with characteristic HCoV negative patients with characteristic
Number or median (n = 37) % or range Number or median (n = 395) % or range
Hospitalized 37 100 395 100
Median length of stay (range) 4 (2–17) 4 (1–20)
Fever 14 37.8 112 28
Oxygen support required 17 45.9 280 70.9
Median duration of oxygen support 3 (2–14) 3 (1–13)
Cough 23 62.2 311 78.7
Rhinorrhea 26 70.3 233 59
Conjunctivitis 1 2.7 16 4
Dyspnea 16 43.2 342 86.6
Wheezing 11 29.7 232 58.7
Vomiting 3 8.1 25 6.3
Diarrhea 1 2.7 7 1.8
Bronchitis 2 5.4 9 2.3
Bronchiolitis 21 56.7 349 88.3
Pneumonia 5 13.5 59 14.9
Recurrent wheezing 3 8.1 57 14.4
Asthma 2 8.7 22 5.6
Otitis media 1 2.7 14 3.5
Recurrent breathing/respiration difficulties 6 16.2 106 26.8
LRTIs 26 70.3 373 94.4
Key: HCoV, human coronavirus; LRTIs, lower respiratory tract infections.
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infections than older children [39]. In other recently pub-
lished study the patients with coronavirus and influenza A
virus coinfections had more severe disease than those with
influenza virus infection only [40].
In the majority of our HCoV-positive specimens
(70%), at least one other viral nucleic acid was present.
To distinguish possible differences in the clinical presen-
tations of children with a single infection from those of
children with coinfections, and between the clinical pre-
sentations of infections with specific HCoV species, a
study with more patients is required.
All HCoV-positive children included in our study were
hospitalized with ARTI: 70.3% had LRTIs and 29.7% had
URTIs. Pneumonia was diagnosed in 13.5% of children
and 56.7% of children had bronchiolitis; 29.7% of HCoV-
positive children had an underlying medical condition.
As reported by others, single infections with HCoV were
more often detected in children with an underlying med-
ical condition than in previously healthy children: 5/11
(45.4%) vs 6/26 (23.1%), respectively [11]. In children
with an underlying disease, the 229E was more often
detected as a single infection than as a coinfection, whereas
the HKU1 was more often detected as a coinfection.
Our study also contains several limitations. Due to the
retrospective nature of the study, clinical data were not
available for all included patients due to the noncompre-
hensive or missing clinical documentation. The reasons
for the missing clinical data were that children were hos-
pitalized due to the respiratory tract infection but were
not stationed in pulmonary department and were dis-
tributed to other departments of the children's hospital
because of the overcrowding. For these patients the clin-
ical records were not available to investigators. Another
limitation of this study is the fact that different samples
were taken in some of the patients i.e. oropharyngeal in-
stead of nasopharyngeal swab) and this could influence
the yields of coronavirus (as well as other respiratory
viruses). However due to the retrospective nature of the
study we couldn't influence the sampling descisions
made at the clinic. The politics of sample collection in
place was that nasopharyngeal swab is preferred as the
optimal sample but in cases where the physical or psy-
chological conditions of the patient would not allow for
safe nasopharyngeal swab collection, the laboratory
would accept the oropharyngeal swab. The samples such
as tracheal aspirates or BAL samples were collected
from the severly affected children. All samples originated
from hospitalized patients and that can also be consid-
ered as source of selection bias. Samples from outpati-
ents and healthy control group children would be
desirable in the study to determine HCoV prevalence
and clinical features more accurately and also to exclude
the possibility that viruses are detected as “contami-
nants” or “normal flora”. Due to the retrospective nature
of the study, follow up testing was not performed. At the
time of the study, detection of respiratory viruses was
routinely performed by DFA instead of PCR which
might underestimate the true prevalence of infections.
However, we believe that these differences in sensitivity
are not very prominent, especially in regard to detection
of RSV virus and the fact that the study population repre-
sents young children in which DFA has best sensitivity.
Conclusions
In conclusion, we found that all four non-SARS corona-
virus were detected with ARTIs in hospitalized children
in Slovenia and that their identification with routine
diagnostic techniques is feasible. An association between
age and the viral load was found. The highest viral load
was detected in children approximately 10 months of
age. Further investigation of HCoV, with the inclusion of
a control group of healthy children, is required to better
understand the clinical importance of HCoV in respira-
tory infections.
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